menu search

Wave life sciences third quarter 2023 financial results scheduled for november 9, 2023

CAMBRIDGE, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delive...

November 3, 2023, 8:05 pm

New preliminary clinical data on potential of opus aav-based gene therapy for rare inherited retinal disease to be presented at the american academy of ophthalmology annual conference 2023

Data to be presented as part of gene augmentation therapy presentation RALEIGH, N.C., Nov. 03, 2023 (GLOBE NEWSWIRE) — Opus Genetics, a patient-focu...

November 3, 2023, 7:43 pm

Davita (dva) to report q3 earnings: what's in the offing?

Improvement in U.S. dialysis treatments per day and cost-saving initiatives are likely to have boosted ...

November 3, 2023, 1:32 pm

Should you still buy the nasdaq's best-performing october stocks?

Structure Therapeutics' weight-loss drug candidate is attracting attention over excitement about obesity treat...

November 3, 2023, 5:20 am

Astrazeneca inks gene editing deal that could end up costing it $2.5bn

AstraZeneca PLC (LSE:AZN) has entered into a partnership and investment deal with French gene editing specialist biotech firm Cellectis (NASDAQ:CLLS) ...

November 1, 2023, 3:59 am

23andme to offer clients personalized action plans based on genetic and other health data

23andMe Holding Co. ME, +0.39% said Tuesday it's launching a health action plan that will offer its clients personalized recommendations based on gene...

October 31, 2023, 8:14 am

Pfizer q3 earnings beat does little for the battered share price

A smaller-than-expected third-quarter loss from Pfizer Inc (NYSE:PFE) was not enough to move the stock pre-market as it revealed the scars from a tail...

October 31, 2023, 8:13 am

Pph: a 'shot in the arm' for investors looking to capitalize on recent pharmaceutical advances

VanEck Pharmaceutical ETF has had the strongest one-year performance of four major pharmaceutical ETF competitors due to its unique mix of Novo Nordis...

October 31, 2023, 3:35 am

Ironwood pharmaceuticals: the right play now

Ironwood Pharmaceuticals, Inc. is a Boston-based drug company focused on developing treatments for gast...

October 27, 2023, 4:13 pm

Treace medical concepts continues growth investments despite high operating losses

Treace Medical Concepts, Inc. sells medical device treatments for foot bunions. The global market for b...

October 27, 2023, 12:09 pm

Bsf enterprise flutters higher as lab-grown cornea subsidiary created

BSF Enterprise PLC (LSE:BSFA) shares fluttered 8% higher to 8.2% after the bio-tissues company formed a division to focus on lab-grown corneas. Kerato...

October 26, 2023, 4:03 am

New data from biogen’s investigational antisense oligonucleotide (aso) targeting tau shows promise for potential new generation of treatments in early alzheimer’s disease

In the Phase 1b study, favorable trends were reported for the high-dose groups on multiple measures of cognition and function. First study of a tau ta...

October 25, 2023, 2:51 pm

Phathom pharmaceuticals to participate in upcoming investor conferences

FLORHAM PARK, N.J., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing ...

October 25, 2023, 8:01 am

Medivir to report new and updated data from ongoing phase 2a hcc study as part of its q3 report on friday

Webcasted Conference Call on Friday, October 27, 2023 at 14.00 CET STOCKHOLM , Oct. 25, 2023 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a ph...

October 25, 2023, 2:46 am

Hims & hers: specialization is the secret to great growth

Hims & Hers Health offers personalized and customized telehealth services, specializing in niche treatments...

October 24, 2023, 10:44 pm

Cargo therapeutics begins $100 million ipo rollout

Cargo Therapeutics, Inc. has filed for a $100 million IPO to develop improved CAR T-cell therapy for large B-cell lymphoma. The company's lead candida...

October 23, 2023, 5:47 pm

Pfizer to price covid drug paxlovid at $1,390 per course

Paxlovid will transition to the private market in November, which comes as demand for Covid vaccines and treat...

October 18, 2023, 5:57 pm

Abbvie: q2 success sets the stage for consistent growth

AbbVie is a leading pharmaceutical company with a strong history and a diverse portfolio of products. The company's flagship product, Humira, has gene...

October 17, 2023, 1:58 pm

Health care select sector fund etf: riding the healthcare boom

The Health Care Select Sector SPDR Fund is an ETF that tracks the performance of the U.S. health care sector. XLV has a diverse portfolio of holdings,...

October 16, 2023, 2:56 pm

Karuna therapeutics: karxt could become a new standard of care in schizophrenia

Karuna Therapeutics, Inc. stock had >8x gain after my Buy rating before successful Phase 3 trial data for KarXT in treating schizophrenia. The stock h...

October 16, 2023, 2:41 pm


Search within

Pages Search Results: